Based on univariate analysis, TMEM60 was found to be a risk factor for the prognosis of glioma patients based on TCGA RNA-seq (Figure 3A; HR = 3.970, 95% confidence interval (CI) = 3.211–4.909, p < .001), CGGA RNA-seq (Figure 3C; HR = 2.067, 95% CI = 1.805–2.367, p < .001), and CGGA RNA-array (Figure 3E; HR = 2.913, 95% CI = 2.049–4.139, p < .001). The gene discussed is TMEM60; the disease is central nervous system cancer.